Get Started

CNBX

OQB CNBX Pharmaceuticals Inc
Oct 25, 2026 · 1:53 PM ET EOD Market Closed

$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001

YTD change
-75.00%
vs 20-day SMA
-25.79%
vs 200-day SMA
-52.04%

Price ranges

Previous day
$0.0001 $0.0001
open $0.0001 close $0.0001
+$0.0000 (+0.00%)
Today
$0.0001 $0.0001
$0.0001
Past week
$0.0001 $0.0002
from $0.0001 now $0.0001
-$0.0000 (-25.93%)
Past month
$0.0001 $0.0002
from $0.0002 now $0.0001
-$0.0001 (-50.00%)
This year
$0.0001 $0.0007
from $0.0004 now $0.0001
-$0.0003 (-75.00%)

Price & Performance

-0.00 (-75.00%) / 6M

$0.0000$0.0001$0.0003$0.0004Apr 27Jul 24Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $5.5000
  • CNBX is down 75% since the beginning of the year
  • CNBX is down 75% over the past 12 months
  • CNBX is down 50% over the past 1 month

CNBX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -66.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0001
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.3M
Beta 1.55

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$9.5K
Debt$1.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeOQB
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $160.6K

CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,273.46 -2.54%
JNJ Johnson & Johnson $263.81 -1.42%
ABBV AbbVie, Inc. $285.64 +0.16%
MRK Merck & Co., Inc. $145.27 -1.34%
RHHBY Roche Holding Ltd Sponsored ADR $61.17 +2.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.